Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROPYLTHIOURACIL Cause Cardiogenic shock? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Cardiogenic shock have been filed in association with PROPYLTHIOURACIL (Propylthiouracil). This represents 1.5% of all adverse event reports for PROPYLTHIOURACIL.

14
Reports of Cardiogenic shock with PROPYLTHIOURACIL
1.5%
of all PROPYLTHIOURACIL reports
4
Deaths
13
Hospitalizations

How Dangerous Is Cardiogenic shock From PROPYLTHIOURACIL?

Of the 14 reports, 4 (28.6%) resulted in death, 13 (92.9%) required hospitalization, and 7 (50.0%) were considered life-threatening.

Is Cardiogenic shock Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROPYLTHIOURACIL. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does PROPYLTHIOURACIL Cause?

Drug ineffective (121) Foetal exposure during pregnancy (110) Anti-neutrophil cytoplasmic antibody positive vasculitis (81) Exposure during pregnancy (75) Hyperthyroidism (58) Off label use (54) Maternal exposure during pregnancy (50) Agranulocytosis (42) Vasculitis (41) Premature baby (38)

What Other Drugs Cause Cardiogenic shock?

AMLODIPINE (779) AMIODARONE (595) BUPROPION (559) ACETAMINOPHEN (466) METOPROLOL (454) BISOPROLOL (413) VERAPAMIL (412) NOREPINEPHRINE (381) HEPARIN (357) METFORMIN (356)

Which PROPYLTHIOURACIL Alternatives Have Lower Cardiogenic shock Risk?

PROPYLTHIOURACIL vs PROTAMINE PROPYLTHIOURACIL vs PROTHIPENDYL PROPYLTHIOURACIL vs PROTIONAMIDE PROPYLTHIOURACIL vs PROTONIX PROPYLTHIOURACIL vs PROTOPIC

Related Pages

PROPYLTHIOURACIL Full Profile All Cardiogenic shock Reports All Drugs Causing Cardiogenic shock PROPYLTHIOURACIL Demographics